This document is an excerpt from the EUR-Lex website
Document 62014TB0672
Case T-672/14 R: Order of the President of the General Court of 15 December 2014 — August Wolff and Remedia v Commission (Application for interim measures — Marketing authorisation for medicinal products for human use — Application for suspension of operation of a measure — Lack of urgency)
Case T-672/14 R: Order of the President of the General Court of 15 December 2014 — August Wolff and Remedia v Commission (Application for interim measures — Marketing authorisation for medicinal products for human use — Application for suspension of operation of a measure — Lack of urgency)
Case T-672/14 R: Order of the President of the General Court of 15 December 2014 — August Wolff and Remedia v Commission (Application for interim measures — Marketing authorisation for medicinal products for human use — Application for suspension of operation of a measure — Lack of urgency)
IO C 81, 9.3.2015, p. 21–21
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
9.3.2015 |
EN |
Official Journal of the European Union |
C 81/21 |
Order of the President of the General Court of 15 December 2014 — August Wolff and Remedia v Commission
(Case T-672/14 R)
((Application for interim measures - Marketing authorisation for medicinal products for human use - Application for suspension of operation of a measure - Lack of urgency))
(2015/C 081/27)
Language of the case: German
Parties
Applicants: Dr. August Wolff GmbH & Co. KG Arzneimittel (Bielefeld, Germany); and Remedia d.o.o (Zagreb, Croatia) (represented by: P. Klappich, C. Schmidt and P. Arbeiter, lawyers)
Defendant: European Commission (represented by: M. Šimerdová, A. Sipos and B.-R. Killmann, acting as Agents)
Re:
Application for the suspension of the operation of Commission Implementing Decision C (2014) 6030 final of 19 August 2014 concerning marketing authorisations for topical medicinal products for human use containing high concentrations of estradiol pursuant to Article 31 of Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use (OJ 2001 L 311, p. 67).
Operative part of the order
|
1. |
The application for interim measures is dismissed. |
|
2. |
The order of 2 October 2014 is cancelled. |
|
3. |
Costs are reserved. |